A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer, according to research published in Cell Reports.
The microRNA, known as miR-223, is highly expressed in blood cells that cause inflammation (neutrophils). When they’re working correctly, those blood cells help protect the human body against infections, but sometimes they damage host tissue instead of microbes, causing chronic inflammation and disease.
To uncover the link between miR-223 and inflammation, a Purdue University research team created a zebrafish totally deficient of miR-223. Then they cut off a small chunk of its fin.
“The inflammation was really robust,” said Qing Deng, a professor of biological sciences at Purdue and corresponding author of the paper. “Neutrophils accumulated at the wound and they just kept coming. This is consistent with the literature, but we wanted to understand why.”
Extensive gene expression analysis led them to pathway NF-kB, a protein complex found in nearly all animal cell types that regulates inflammation and cell proliferation. Heightened activation of this pathway is the cause of increased inflammation, although it’s limited to the deeper, or basal, layer of the epithelium. This means any therapeutics would need to reach the basal layer to work.
The same pathway plays an important role in human bronchial epithelial cells, which are critical in the development of asthma, according to the study. MiR-223 suppresses the pathway, which means supplementing it to epithelial cells could help control inflammatory disease.
“We don’t have human trials yet, but we think it’s promising,” Deng said. “Instead of using steroids to drive away the immune cells, maybe this microRNA could be given.”
Learn more: MicroRNA could help treat cancer and asthma
The Latest on: MicroRNA
via Google News
The Latest on: MicroRNA
- Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545on August 13, 2019 at 3:21 am
We here tested expression and potential functions of circular RNA PRKCI (circPRKCI) in human glioma. Our results show that circPRKCI is upregulated in human glioma tissues and glioma cells, ...
- Visiongain Launches New Report: Epigenetics Diagnostic Report 2019-2029on August 12, 2019 at 8:03 am
Some of the examples consists of activating changes namely histone acetylation and DNA demethylation, repressive changes like DNA methylation and histone modifications influenced by noncoding RNAs, ...
- 26 jobs lost at Boulder’s MiRagen as part of corporate restructuringon August 8, 2019 at 7:00 pm
It will help the company to focus on the clinical development of cobomarsen, being developed for the treatment of blood cancers; and microRNA-29 mimics including remlarsen being developed for the ...
- Regulus Therapeutics Reports Second Quarter 2019 Financial Results and Recent Updateson August 8, 2019 at 1:10 pm
The Company expects to use the proceeds from the Private Placement primarily to advance RGLS4326 for the treatment of autosomal dominant polycystic kidney disease ("ADPKD"), to advance select programs ...
- How This Rock Star, Ph.D., and Pilot Added 'Hot Sauce Mogul' To His Long List of Accomplishmentson August 8, 2019 at 7:53 am
(His dissertation title is Discovery of Mature MicroRNA Sequences within the Protein-Coding Regions of Global HIV-1 Genomes: Predictions of Novel Mechanisms for Viral Infection and Pathogenicity.) So ...
- miRagen Therapeutics' (MGEN) CEO Bill Marshall on Q2 2019 Results - Earnings Call Transcripton August 7, 2019 at 9:14 pm
MRG-110 represents the third microRNA targeted product candidate from our team has developed. That has been generally safe and well tolerated and with preliminary proof of mechanism data in humans.
- Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinomaon August 7, 2019 at 6:41 am
Many patients diagnosed with oesophageal adenocarcinoma (OAC) present with advanced disease and approximately half present with metastatic disease. Patients with localised disease, who are managed ...
- Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongueon August 7, 2019 at 5:26 am
Numerous studies have highlighted that long non-coding RNAs (lncRNAs) can bind to microRNA (miRNA) sites as competing endogenous RNAs (ceRNAs), thereby affecting and regulating the expression of mRNAs ...
- miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuringon August 7, 2019 at 2:05 am
Cost Restructuring Plan miRagen announced it will also implement a cost restructuring plan focused on reducing costs and directing its resources to advance cobomarsen and microRNA-29 mimics, including ...
- HDO-antimiR represents a new weapon in the fight against microRNA-related diseaseon July 26, 2019 at 8:42 am
MicroRNA (miRNA) is a type of RNA that plays an important role in various cellular processes and is also involved in developing defenses against pathogens. Increasing numbers of studies have ...
via Bing News